4-((2-CYCLOBUTYL-1H-IMIDAZO(4,5-B)PYRAZIN-1-YL)METHYL)-7,8-DIFLUORO-2(1H)-QUINOLINONE HYDROCHLORIDE
UNII KA5QAY2P2Q
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-((2-cyclobutyl-1h-imidazo(4,5-b)pyrazin-1-yl)methyl)-7,8-difluoro-2(1h)-quinolinone Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KA5QAY2P2Q.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1125748-85-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H15F2N5O.ClH OPTUUCXGUUEYES-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-((2-cyclobutyl-1h-imidazo(4,5-b)pyrazin-1-yl)methyl)-7,8-difluoro-2(1h)-quinolinone Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.